M. Sokal

Bone-targeted radium-223 in symptomatic, hormone-refractory prostate cancer: a randomised, multicentre, placebo-controlled phase II study

Sten Nilsson, Lars Franzén, Christopher Parker et al. · The Lancet Oncology · 2007 · 493 citations

Medicine, Oncology, Radiation Oncology +15

The United Kingdom Children’s Cancer Study Group’s Second Germ Cell Tumor Study: Carboplatin, Etoposide, and Bleomycin Are Effective Treatment for Children With Malignant Extracranial Germ Cell Tumors, With Acceptable Toxicity

Jillian R. Mann, F. Raafat, Katie Robinson et al. · Journal of Clinical Oncology · 2000 · 277 citations

Medicine, Oncology, Pediatrics +17

Prognostic factors for survival in patients with advanced renal cell carcinoma treated with recombinant interleukin-2

Peter Palmer, J. Vinke, Thierry Philip et al. · Annals of Oncology · 1992 · 156 citations · Full text

Medicine, Immunology, Oncology +14

Two-Year Survival Follow-Up of the Randomized, Double-Blind, Placebo-Controlled Phase II Study of Radium-223 Chloride in Patients With Castration-Resistant Prostate Cancer and Bone Metastases

Sten Nilsson, Lars Franzén, Christopher Parker et al. · Clinical Genitourinary Cancer · 2012 · 119 citations

Medicine, Oncology, Radiation Oncology +17

Oral Sodium Clodronate for Nonmetastatic Prostate Cancer--Results of a Randomized Double-Blind Placebo-Controlled Trial: Medical Research Council PR04 (ISRCTN61384873)

M. D. Mason, Matthew R. Sydes, J. Glaholm et al. · JNCI Journal of the National Cancer Institute · 2007 · 106 citations · Full text

Medicine, Oncology, Pharmacotherapy +17